5N PLUS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.41 CAD | +1.50% |
|
+5.87% | +43.12% |
| May. 09 | 5N Plus Inc. Appoints Andrée-Lise Méthot as Director | CI |
| May. 09 | Transcript : 5N Plus Inc. - Shareholder/Analyst Call |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 278M 378M | Sales 2025 * | 310M 422M | Capitalization | 353M 481M |
|---|---|---|---|---|---|
| Net income 2024 * | 14M 19.08M | Net income 2025 * | 20M 27.25M | EV / Sales 2024 * | 1.58 x |
| Net Debt 2024 * | 85.83M 117M | Net Debt 2025 * | 69.23M 94.33M | EV / Sales 2025 * | 1.36 x |
| P/E ratio 2024 * |
22.1
x | P/E ratio 2025 * |
15.3
x | Employees | 780 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on 5N Plus Inc.
More recommendations
More news
| 1 day | +1.50% | ||
| 1 week | +5.87% | ||
| Current month | +15.85% | ||
| 1 month | +12.24% | ||
| 3 months | +25.23% | ||
| 6 months | +61.98% | ||
| Current year | +43.12% |
1 week
5.07
5.43
1 month
4.545.43
Current year
3.335.43
1 year
2.865.43
3 years
1.035.43
5 years
1.015.43
10 years
0.925.43
| Managers | Title | Age | Since |
|---|---|---|---|
Gervais Jacques
CEO | Chief Executive Officer | - | 20-04-30 |
Richard Perron
DFI | Director of Finance/CFO | 51 | 14-03-16 |
Paul Tancell
PRN | Corporate Officer/Principal | - | 17-02-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 07-12-31 | |
Luc Bertrand
CHM | Chairman | 73 | 16-01-10 |
Gervais Jacques
CEO | Chief Executive Officer | - | 20-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 5.41 | +1.50% | 103,657 |
| 24-05-15 | 5.33 | +1.91% | 301,677 |
| 24-05-14 | 5.23 | +0.97% | 59,672 |
| 24-05-13 | 5.18 | +1.17% | 51,545 |
| 24-05-10 | 5.12 | +0.20% | 32,954 |
Delayed Quote Toronto S.E., May 16, 2024 at 04:00 pm EDT
More quotes
5N Plus Inc. is a global producer of specialty semiconductors and performance materials. The Company deploys a range of technologies to develop and manufacture its products. It operates through two segments: Specialty Semiconductors and Performance Materials. Operating in North America and Europe, the Specialty Semiconductors segment manufactures and sells products used in several applications, such as renewable energy, space satellites and imaging. Its end markets include photovoltaics (terrestrial and spatial solar energy), medical imaging, infrared imaging, optoelectronics, and advanced electronics. The Performance Materials segment operates in North America, Europe and Asia and manufactures and sells products that are used in several applications in pharmaceutical and healthcare, industrial, and extractive and catalytic. Main products are sold as active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, and engineered powders.
Sector
Specialty Chemicals
Calendar
2024-07-29
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.973
USD
Average target price
4.794
USD
Spread / Average Target
+20.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +43.12% | 353M | |
| +17.29% | 66.43B | |
| +2.81% | 49.89B | |
| +17.88% | 41.88B | |
| +20.88% | 26.48B | |
| +11.82% | 19.68B | |
| +0.19% | 17B | |
| -21.87% | 16.12B | |
| +0.91% | 15.28B | |
| -10.58% | 15.18B |
- Stock Market
- Equities
- VNP Stock
